NSGC’s Webinar Series is a timely, year-round series program focused on education and other issues impacting our profession. From telemedicine to genetic engineering, these webinars keep you apprised of how the latest trends in healthcare may affect you.

Webinars are free for all members to view, and can be purchased for CEU’s either individually or as a full series. The five webinar package will be available for purchase soon.

If you have any questions about the NSGC Member Webinar Series, please feel free to review the FAQ document below or to contact NSGC Webinar Subcommittee members, Alice Zalan or Tanya Eble.

 

2023 Webinar Series FAQ Sheet 

NSGC Sponsored Webinar Series

 

2023 Webinar Series

 

 

September 20th, 2023, 12:00pm-1:00pm CT
Topic: COMING SOON!
Presenting SIG: Prenatal SIG 

Click here to Register

 

 

September 6th, 2023, 12:00pm-1:00pm CT
Topic: COMING SOON!
Presenting SIG: Inpatient SIG 

Click Here to Register 

 

 

August 30th, 2023, 12:00pm-1:00pm CT
Topic: COMING SOON!
Presenting SIG: Cardiovascular SIG

Click here to Register

 

 

August 23rd, 2023, 12:00pm-1:00pm CT
Topic: COMING SOON!
Presenting SIG: Genomic Technologies 

Click here to Register

 

 

August 9th, 2023, 12:00pm-1:00pm CT
Topic: COMING SOON!
Presenting SIG: Renal SIG 

Click here to Register

 

 

July 26th, 2023, 12:00pm-1:00pm CT
Topic: COMING SOON!
Presenting SIG: Lab/ Industry SIG 

Click here to Register

 

 

July 12th, 2023, 12:00pm-1:00pm CT
Topic: A New PGT-A Horizon: Segmenral Aneuploid Embryos & Their Transfer
Presenting SIG: ART/Infertility SIG 

Learning Objective #1
Describe the origins and implications of segmental aneuploidy in a trophectoderm biopsy

Learning Objective #2
Review the outcomes and counseling considerations for segmental aneuploid transfers

Please share a brief outline of how you will utilize the hour webinar time.

- Review pre and postnatal implications of segmental aneuploidy detection and knowledge of audience coming into the webinar
- Discuss PGT-A testing, detection of segmental aneuploidy and limited clinical validation studies in the industry
- Explore incidence and origins of segmental aneuploid trophectoderm biopsy results and discuss replication research on donated embryos
- Review current data on embryo transfer outcomes
- Explore recommendations for prenatal follow-up testing
- Hypothesize future avenues
- Q&A Period

Click here to Register

 

 

June 26th, 2023, 12:00pm-1:00pm CT
Topic: COMING SOON!
Presenting SIG: NASEM Roundtable on Genomics and Precision Health 

Click here to Register

 

June 14th, 2023, 12:00pm-1:00pm CT
Topic: COMING SOON!
Presenting SIG: Leadership & Management SIG 

Click here to Register

 

 

May 17th, 2023, 12:00pm-1:00pm CT
Topic: COMING SOON!
Presenting SIG: Metabolic SIG  

Click Here to Register

 

May 3rd, 2023, 12:00pm-1:00pm CT
Topic: COMING SOON!
Presenting SIG: Neuro SIG

Click Here to Register

 

April 19th, 2023, 12:00pm-1:00pm CT
Topic: Personalized Medicine, Pregnancy & Prenatal Counseling; A Modern Look at Cystic Fibrosis 
Presenting SIG: CF and CFTR Spectrum

Learning Objective #1
Describe how genotype specific treatments have impacted health and quality of life outcomes in cystic fibrosis.

Learning Objective #2
Identify clinical situations that benefit from genotype specific counseling and discussion of targeted therapeutics.

Learning Objective #3
Summarize what is known regarding the effects of CFTR modulators on pregnancy outcomes.

Speaker 1:
Charlotte Close, MS, CGC
BIO: Charlotte is a pediatric genetic counselor at Columbia University Medical Center who collaborates and sees patients with the Pediatric CF Team at Columbia.
Speaker 2:
Kimberly Foil, MS, CGC
BIO: Kimberly is a member of the cystic fibrosis care team at the Medical University of South Carolina. She provides genetic counseling for pediatric and adult patients and families affected by CF and is engaged in CF newborn screening follow-up.

Webinar description:
Highly effective modulator therapy has revolutionized the landscape of cystic fibrosis (CF) treatment and outcomes. During this webinar, an overview of CFTR modulator therapies will be presented with emphasis on applications in the prenatal genetic counseling setting. The molecular basis of CFTR modulators and genotype eligibility will be reviewed, along with exploration of how modulator therapies have changed the course of CF. Approaches to incorporate modern information into prenatal screening and diagnosis counseling will be discussed. Additionally, increasing numbers of women with CF are pursuing pregnancy, and case reports of in utero CF treatment have emerged. Current data regarding maternal-fetal risks, benefits, and unknowns of modulator use during pregnancy will be explored with real-world case examples presented.

Click Here to Register

 

April 5th, 2023, 12:00pm-1:00pm CT
Topic: When Two is Better than One: Roles for Paired Somatic Testing
Presenting SIG: Cancer SIG  

Presenters:
Angela Jacobson, MS, CGC, LGC and Colin C. Pritchard, MD, PhD

Learning Objective 1:
Identify clinical scenarios where paired somatic germline testing aids in the diagnostic work up for hereditary cancer
Learning Objective 2:
Outline the role of paired tumor-normal testing for patients with advanced cancer needing treatment decisions
Learning Objective 3:
Define clonal hematopoiesis and understand how this phenomenon impacts both plasma cell-free tumor DNA and germline cancer risk testing

Click Here to Register

 

March 22nd, 2023, 11:00am-12:00pm CT
Topic: The Genetic Testing Industry: How Things Work and Why They May Need Changing
Presenting SIG: Genomic Technologies 

Learning Objective 1: 
Describe the process involved in bringing an LDT to market

Learning Objective 2:
Compare the regulatory requirements between FDA and CMS (CLIA)

Learning Objective 3:
Examine how global events impact the commercial genetic testing industry

Speaker 1:
Lisa Edelmann

Speaker 2:
Yuriy Shevchenko

Click here to Register

 

March 14th, 2023, 1:00pm-2:00pm CT
Topic: Psychiatric genetic counseling: emerging access points through holistic primary care and precision medicine integration
Presenting SIG: Psychiatric SIG 

Learning Objective #1
Consider new and emerging access points to psychiatric genetic counseling through primary care

Learning Objective #2
Compare and consider the different models of service delivery and psychiatric genetic counseling considerations for pre-test counseling and pharmacogenetic results disclosure

Learning Objective #3
Examine the experience, including benefits and challenges, of implementing psychopharmacogenetics service delivery through multidisciplinary team based primary care

Learning Objective #4
Describe the unique genetic counselor and pharmacist partnership in the pharmacogenetic (PGx) guided psychiatric medication journey for patients/clients

Speaker #1
Prescilla Carrion, MSc, CGC, CCGC - Genetic Counsellor and Clinical Associate Professor
UBC Department of Psychiatry + Genetic Counsellor at Medcan, Toronto, Ontario, Canada
prescilla.carrion@ubc.ca

Speaker #2
Christine Munro, MS, MPH, CGC - Genetic Counselor at UPMC Primary Care Precision Medicine Clinic + Director of Recruitment and Admissions for the University of Pittsburgh Genetic Counseling Program

Speaker #3
Natasha Berman, MA, MS, MPH, CGC - Genetic Counselor at UPMC Primary Care Precision Medicine Clinic, Department of Family Medicine
bermannr@upmc.edu

Click Here to Purchase CEU's 

 

 

February 22nd, 2023, 12:00pm-1:00pm CT

Topic: Genome vs exome sequencing: everything you should know

Learning Objective #1
Explore the fundamental difference between Exome and Genome sequencing: workflow, coverage, and uniformity.

Learning Objective #2
Demonstrate the technical superiority of genome sequencing over exome sequencing through case studies

Speaker #1
Fen Guo; PerkinElmer Genomics

Dr. Fen Guo is board certified in Laboratory Genetics and Genomics by the American Board of Medical Genetics and Genomics (ABMGG) and in Molecular Genetics by the  Canadian College of Medical Geneticists (CCMG). Dr. Guo earned her PhD in Medical Engineering and then completed her post-doctoral training at the University of Western Ontario. Dr. Guo worked at the Molecular Diagnostic Lab at London Health Science Centre before she started her LGG fellowship training at the  University of Wisconsin, Madison.  Dr. Guo joined PerkinElmer Genomics in 2020 where she serves as a clinical reporting director while also overseeing the clinical production and R&D for the NGS section of PerkinElmer Genomics.

Click Here to Purchase CEU's 

 

February 8th, 2023, 12:00pm-1:00pm CT

Topic: Building Business Cases to Solve Everyday Problems

Learning Objective #1
Overview the purpose of a business case and the elements required to build one.

Learning Objective #2
Understand the relevance of business cases for genetic counselors and recognize opportunities for building a business case.

Learning Objective #3
Describe how the core skills used by genetic counselors can be used to build a business case.

Learning Objective #4
Review the NSGC business case toolkit and the resources available to help genetic counselors build a business case.

Please share a brief outline of how you will utilize the hour webinar time.
The first 30-35 minutes will be a didactic overview of business cases, their purpose and how to build one. The next 15 minutes will be spent reviewing the business case toolkit and template to orient listeners to the resources available through NSGC.

Speaker #1      Breanna Roscow, MS, CGC Breanna.roscow@myriad.com Myriad Genetics Vice-chair Access and Service Delivery Committee

Breanna Roscow, MS, CGC is a Regional Medical Specialist in oncology at Myriad Genetics. She is currently the vice-chair of the NSGC Access and Service Delivery committee, and formerly the chair of the Business Case Workgroup. As part of her work with these committees, she helped to coordinate the first NSGC Business Case Summit, is an author the NSGC Business Case whitepaper and helped lead the creation of the NSGC Business Case Toolkit.

Speaker #2      John Zimmerman 

John Zimmerman is a certified genetic counselor with the UT Southwestern Medical Center Cancer Genetics Program. He earned his master’s degree in genetic counseling from the University of Minnesota in 2017. John is the vice-chair of the Business Case Working Group of the NSGC Access and Service Delivery Committee and has helped to develop the NSGC Business Case Toolkit. John’s clinical and research interests focus on using health technology solutions to increase access to genetic services.

Please describe how this session will address Justice, Equity, Diversity, and Inclusion issues relative to the speakers, audience, patient population, and/or other relevant components and content of the session proposal.
Developing business cases allow GCs to advocate for practicing at the top of their scope which improves access to genetic counseling services. Also, JEDI is addressed in my slides to encourage listeners to think about these issues as they build their business cases.

Click Here to Purchase CEU's

 

 

January 25th , 2023, 12:00pm-1:00pm CT

Topic: Evidence-based Consensus Guidelines for Genetic Counseling and Testing in ALS

Presented By: Neuro SIG

Learning Objective #1

• Provide an evidence- based genetic testing and counseling to persons with ALS

Learning Objective #2

• Select appropriate testing laboratory and methodology for C9orf72 and other genes 

Learning Objective #3

• Discuss evidence-based, consensus process for guideline development which may be applied to other neurogenetic evaluations

Please share a brief outline of how you will utilize the hour webinar time.

The practice of genetic testing in ALS has been impacted by high patient demand for testing, sponsored testing programs, and a new drug application to the FDA for the first gene-targeted therapy in ALS. However, many challenges exist, including few genetic counselors in ALS clinics, and issues with laboratory methods and reporting. Jennifer Roggenbuck, MS, CGC will present new evidence-based, consensus guidelines for genetic counseling and testing in ALS, a project sponsored by the ALS Association.

Speaker #1

Jennifer Roggenbuck,

Jennifer.Roggenbuck@osumc.edu;

Ohio State University

Jennifer Roggenbuck is a genetic counselor and Associate Professor at the Ohio State University, where she studies testing and counseling outcomes and best practices in ALS clinical genetics.

Click Here to Purchase CEU's 

 

2022 Webinar Series

If you would like to purchase CEU's for the entire webinar series click here. (All 25 webinars included in purchase will be added once content is released) 

 

January 26, 2022, 12:00pm-1:00pm CT
1000 Mosaic Embryos and More: Status Update on PGT-A Intermediate Copy Number

Presented By: ART/Infertility SIG
Speaker: Andria G. Besser, CGC, NYU Langone Fertility Center 

Andria Besser is a board-certified genetic counselor and the Director of Reproductive Genetics at the NYU Langone Fertility Center. She obtained her Master's in Genetic Counseling at Mount Sinai School of Medicine, and has been specializing in assisted reproductive technologies for the last 12 years. She is a past Chair of the NSGC ART/Infertility SIG and an active member of the American Society for Reproductive Medicine's Genetic Counseling Professional Group and Patient Education Committee. She has co-authored several publications about preimplantation genetic testing, including the ASRM committee opinion on embryonic mosaicism. 

Learning Objectives:

• Describe how embryonic mosaicism is inferred via preimplantation genetic testing for aneuploidy (PGT-A) and recognize the limitations of
  this diagnosis.
• Differentiate between the significance of mosaic results identified in the preimplantation embryo from those identified in the prenatal and
  postnatal period.
• Examine current data surrounding outcomes of mosaic embryo transfers.

To purchase CEUs for this webinar click here. 

February 9, 2022, 12:00pm-1:00pm CT

Genetic Testing in Individuals with Cerebral Palsy

Presented By: Pediatric and Clinical SIG
Speaker: Halie May, CGC, Columbia University Irving Medical Center 

Halie is a genetic counselor at the Institute for Genomic Medicine at Columbia University Irving Medical Center and a faculty member of the Department of Medicine, who specializes in cerebral palsy genetics and genomics. She collaborates with the Weinberg Family Cerebral Palsy Center in the Departments of Orthopedics at CUIMC and has most recently published 'Genetic testing in individuals with cerebral palsy', a cohort study describing the diagnostic rates in patients with and without known environmental etiologies for CP.

Learning Objectives:

• Classify clinical features of genetic and non-genetic forms of cerebral palsy (CP)
• Identify different genes involved in CP
• Integrate current genetic research on CP into practice
• Evaluate appropriate genetic testing work up for patients with CP
• Discuss emotional implications of a genetic diagnosis in a patient with CP

To purchase CEUs for this webinar click here. 

February 23, 2022 12:00pm-1:00pm CT

Strategies for Self-Care and Mindfulness 

Presented By: 2022 Webinar Subcommittee
Speaker: Nadine Channoui, MS, CGC

Learning Objectives: 

• Locate resources relevant to self-care planning.​
• Experience one practice of guided meditation.
• Identify multiple forms of self-care, collective-care, and mindfulness.

To Purchase CEU's for this webinar click here

March 11th, 2022 12:00pm-1:00pm CT

Preimplantation Genetic Testing for the Genetic Counselor

Presented By: 2022 Webinar Subcommittee
Speaker: Sheila Johal

Learning Objectives: 

• Summarize the methodology of PGT-M
• Examine challenging indications for PGT-M using case examples.
• Identify how genetic counselors may assist patients pursuing PGT-M

To Purchase CEU's for this webinar click here

March 23rd, 2022 12:00pm-1:00pm CT

Writing High Quality Abstracts- Insights from the Abstract Review Workgroup

Presented By: 2022 Webinar Subcommittee
Speaker: Katie Lewis and Sharon Aufox

Learning Objectives: 

• Summarize the Abstract WG process and criteria for reviewing abstracts  
• Evaluate high quality abstracts for their strengths
• Identify practical tips for creating high quality abstracts 

Katie Lewis trained at the Johns Hopkins genetic counseling training program and currently works at the Center for Precision Health Research at the National Institutes of Health. Her research interests are in the use of genomic sequencing in healthy and underrepresented populations, alternative service delivery modes and the social and behavioral outcomes of patients who receive secondary findings. She is the 2022 Chair of the NSGC Abstract Review Workgroup.

Sharon Aufox’s Bio

Sharon graduated with a Master of Science degree in Human Genetics from the Sarah Lawrence Genetic Counseling Program in 1996. Following graduation, Sharon worked as a prenatal and pediatric genetic counselor as well as a laboratory genetic counselor at Wake Forest University in Winston-Salem, NC from 1996-2000, and then as prenatal genetic counselor for Rockford Memorial Hospital until 2002.   Since 2002, Sharon has worked for Northwestern University. She worked for 18 years on a genetic biobank and was involved in several different related research projects including the Northwestern site of the eMERGE Network. Recently, she has been working on a gene discovery clinical study involving children with suspected genetic conditions and is the Assistant Director of Northwestern University’s graduate program in Genetic Counseling.  In addition to helping teach the program’s research methods course, she has mentored almost 50 graduate students with their thesis projects. 

To purchase CEU's for this webinar click here

April 6, 2022 12:00pm-1:00pm CT 

Topic: An update on the genetic landscape of hearing loss through the lens of Usher Syndrome

Presented By: Opthamology & Hearing Loss SIG 
Speakers: Marina Dutra-Clarke, Dana Schlegel

Learning Objectives: 

• Examine the utility of genetic counseling and testing for isolated and syndromic hearing loss
• Evaluate the psychosocial implications of vision loss at different stages of disease

Marina Dutra Clark Bio: 
Marina Dutra-Clarke is a board certified genetic counselor and licensed in California. She received her Master’s degree in genetic counseling at the University of California, Irvine. She is currently a pediatric genetic counselor at UCLA where her role has a focus on hearing loss, chromosome 22q11.2 deletion syndrome, and general pediatrics. Most recently, she developed a genetic counselor-led hearing loss clinic for patients with non-syndromic hearing loss. Marina is also a clinical supervisor and lecturer for the UCLA genetic counseling master’s program.

Dana Schlegel Bio

Dana Schlegel is a certified genetic counselor licensed in Michigan.  She has been a genetic counselor at the Kellogg Eye Center of Michigan Medicine for the past 8 years, where she sees patients with retinal dystrophies and retinoblastoma. She received her MS in Genetic Counseling and MPH in Health Behavior & Health Education at the University of Michigan in 2014.  In addition to seeing patients in clinic, Dana is involved in classroom and clinical teaching.  She has also been involved in the Deaf community in various settings over the years.

To purchase CEU's for this webinar click here

 

May 4, 2022 12:00pm-1:00pm CT

Topic:  J.E.D.I. initiatives and Considerations for Genetic Counseling Student Lab/Industry Rotations.

Presented By: Lab and Industry SIG
Speakers:  Michelle Moore, Tara Hart, Carla McGruder, Timikia Vaughn

Learning Objectives: 

• Illustrate actionable ways to incorporate DEI initiatives into lab/industry educational opportunities for current and prospective genetic counseling students
• Discuss strategies to improve the equity of how GC rotations and educational opportunities are offered
• Recognize strategies to increase accessibility for lab/industry rotations for current and prospective genetic counseling students
• Identify calls to action to integrate DEI initiatives into genetic counseling training

Michelle Moore will begin by discussing a recent Journal of Genetic Counseling publication, "A call for unity in DEIJ efforts using a proposed framework for Education, Recruitment, Retainment, Research, and Active outreach (ERA) for genetic counselors in the United States." Michelle will introduce a DEI framework, including concepts that all GC programs should implement and discuss the unique considerations of lab/industry rotations in particular.

Tara Hart will discuss microinclusions and how supervisors can foster an inclusive learning environment. Tara will highlight Stanford resources and how to apply these resources in GC education and training. Additionally, Tara will discuss how GeneDx has worked to increase accessibility to lab/industry rotations for GC students and prospective students.

Carla McGruder will discuss the GC Immersive program at Color, which helps prospective students from underrepresented groups in the field advance their knowledge of the GC profession and bolster their preparedness as a candidate for GC training.

Timikia Vaughn will discuss the summer GC internship program at Natera, which is DEI focused. Timikia will discuss the challenges of offering rotations to students in an equitable and accessible manner.

To Purchase CEU's for this webinar click here 

 

May 18th, 2022 12:00pm-1:00pm CT

Topic: Career Transition Roadmap: Taking a Strategic View of Your Career

Presented By: Late Career Sig

Learning Objectives: 

• Identify key life priorities as they apply to career
• Identify and prioritize core values as they apply to career
• Develop a strategy for determining career transition status
• Identify one executable action to move closer to your career goal

Are you thinking about making a job change, industry change or a career change?  Are you re-thinking your work and life priorities?  Are you asking yourself: “Should I stay, or should I go?”

If yes, this webinar will provide you with a career transition roadmap that gives you tools to navigate the process more easily:  how to prepare yourself, ideas on how to approach the decision-making process, and how to better manage your mindset and emotions as you navigate the uncertainty of change.

As a participant, you will receive a set of “self-reflection” exercises after the workshop that will help clarify what is most important to you as you consider next steps in your career.

To Purchase CEU's for this webinar click here

 

May 25th, 2022 1:00pm-2:00 pm CT

Topic: What’s new in Pharmacogenomics (PGx) in Psychiatry: Emerging research evidence and considerations for clinical utility, implementation, and counseling.

Presented By: Psychiatric SIG 

Learning Objectives: 

• Examine the evidence for using PGx testing to guide depression treatment as compared to treatment as usual.
• Compare patient and providers’ perceptions of PGx testing for depression and its clinical implementation within a public healthcare system.
• Summarize patient preferences and needs for accessing PGx testing for depression, and the resulting considerations for pre- and post-test counseling.

 Outline of how the webinar time will be utilized.

1. 20 minutes for the 1st presentation on the meta analysis of data on the utility of pharmacogenomic testing for depression. (Title: “Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: a rapid review and meta-analysis”)

     Will PGx help improve outcomes for individuals with depression (e.g., supporting remission and reducing adverse medication effects?)

     Goal: increase GC awareness of the current research on the utility of PGx testing to support depression treatment specifically through meta-analysis of randomized control trials and discuss where more research is needed.

2. 20 minutes for presentation on qualitative research (“Pharmacogenomic testing for major depression: a qualitative study of the perceptions of people with lived experience and professional stakeholders”) looking at how PGx may be helpful and best delivered from the perspective of individuals with lived experience of depression.

     Goal to help inform GC awareness and understanding of what would be helpful to include in a PGx genetic counseling session as informed by the lived experience of individuals with depression.

     Another consideration is what is within the scope of a GC to discuss in a PGx counseling session with a patient/client. What other health care providers need to be consulted/included to meet patient/client needs?

3. 20 minutes panel discussion (we plan to review questions submitted via the chat as well as received real-time at the end of the speaker presentations).

Click here to Purchase CEU's 

 

 

June 1st, 2022 12:00pm-1:00 pm CT

Topic: ¿Qué dijo?: Identifying resources to support Spanish speaking patients within genetic counseling 

Presented By: Spanish Development SIG
Speakers: Cheyla Clark, MPH, MS, CG, Maria Hernandez, B.S, Amanda de Leon, MS, CGC

Learning Objectives: 

• Define language proficiency in healthcare and implications for genetic counseling.
• Explore and recognize the landscape of Spanish language resources and how to find them
• Understand the development of the Spanish working group at a specific institution and the process for reviewing Spanish language documents

Speaker #1 

Cheyla Clark, MPH, MS, CGC cheyla.clark@utsouthwestern.edu UT Southwestern Medical Center

Speaker #2 

Maria Hernandez, B.S;  Maria.Hernandez@utsouthwestern.edu UT Southwestern Medical Center

Speaker #3 

Amanda de Leon, MS, CGC amanda.deleon@utsouthwestern.edu UT Southwestern Medical Center

We plan to promote equity in genetic counseling services for both Spanish speaking patients as well as English speaking patients through resources available at institutional and national levels.

To Purchase CEU's for this webinar click here

 

June 15, 2022 12:00pm-1:00pm CT

Cell‐Free DNA Sequencing for Early Cancer Detection

Presented by Cancer SIG 

Description

Learning Objective #1
Understand some of the challenges with the collection, generation, and interpretation of liquid biopsy data in clinical studies

Learning Objective #2
Become acquainted with different biological aspects of cell-free DNA and associated technologies to detect early cancer

Learning Objective #3
Become acquainted with initatives in hereditary cancer to assess the use of cell-free DNA sequencing technologies for cancer screening

Our speaker will give an overview of the technology, utilization and challenges of liquid biopsy, which is a newer testing methodology that the general genetic counseling community may not have significant knowledge of.

Dr. Trevor Pugh, PhD, FACMG is a cancer genomics researcher, board-certified molecular geneticist, and holder of the Canada Research Chair in Translational Genomics. He is Director of the Joint Genomics Program of the University Health Network and Ontario Institute for Cancer Research which supports basic, translational, and clinical research. He is appointed as an Associate Professor in the University of Toronto Department of Medical Biophysics, Senior Scientist at the Princess Margaret Cancer Centre, and Senior Investigator at the Ontario Institute for Cancer Research. His research lab is focused on understanding clinical implications of clonal shifts in cancer and immune cells during treatment, most recently using cell-free DNA, immune repertoire, and single cell RNA-seq sequencing. Most recently, he was recognized by Canada's Top 40 Under 40, a Terry Fox New Investigator Award, and inclusion on the Web of Science Highly Cited Researchers List.

To Purchase CEU's for this Webinar Click Here

 

June 29, 2022 12:00pm-1:00pm CT

Topic: Introduction to genetic testing and counseling in nephrology

Presented By: Renal SIG

Learning Objective #1
Participants will be able to: Differentiate between different subtypes of kidney disease and identify the major indications for genetic testing in nephrology

Learning Objective #2
Participants will be able to: Recognize genetic conditions of the kidney and their unique counseling and genetic testing concerns

Learning Objective #3 
Participants will be able to: Summarize the role of a genetic counselor in an adult nephrology clinic

Kelsie Bogyo is a genetic counselor at Columbia University Medical Center. She works with adult and pediatric patients with constitutional disorders, primarily with individuals who have kidney disease. She holds a faculty position as Lecturer in Genetic Counseling and is engaged in teaching and supervising Columbia University genetic counseling graduate students in their nephrogenetics internship. Kelsie is involved in multiple research studies focused on understanding the genetic causes of kidney and liver diseases, for which she primarily interprets genomic data and returns genetic results to participants and providers. She also provides laboratory genetic counseling services for the Precision Genomics Laboratory at Columbia. Originally from California, Kelsie migrated east to complete her genetic counseling graduate education at the Icahn School of Medicine at Mount Sinai in New York City.

To purchase CEUs for this webinar click here

 

 

July 13, 2022 12:00pm-1:00pm CT

Topic: Consumer-Initiated Genetic Testing: The Genetic Counselor’s Role

Presented By: Precision Medicine SIG 

Learning Objective #1

Identify the benefits and limitations of various types of consumer-initiated genetic tests (CIGT)

Learning Objective #2

Discuss the variety of roles genetic counselors play when patients present to clinic with CIGT test results

Learning Objective #3 

Review the unique psychosocial strategies involved in achieving genetic counseling goals and patient satisfaction when testing was initiated by the patient

Consumer-initiated genetic tests represent a very large proportion of the genetic testing that occurs in the US, but is often not conducted in the setting of genetic counseling. Research shows it is more likely than clinical genetic testing to be accessed by individuals of diverse demographics, backgrounds, and geographies. The goal of this session is to provide resources and information to genetic counselors on ways in which we can better provide our services to patients in this diverse population.

A moderator will review the basics of CIGT including definitions, landscape, benefits, and limitations. Three cases from three different presenters will be reviewed to highlight common principles of CIGT and the impact on genetic counseling practice. We will end the hour with at least ten minutes for Q&A from the audience.

Gretchen Thone Bio

Click here to Purchase CEU's 

 

July 25, 2022 12:00pm-1:00pm CT

Topic: Organizational Change Methods to Decrease Clinician Burnout

Presented By: 2022 Webinar Subcommittee

Learning Objective #1
Identify organizational strategies to reduce employee burnout and improve engagement

Learning Objective #2
Apply evidence-based practices and behavioral change models to reduce employee burnout.

Please share a brief outline of how you will utilize the hour webinar time.

1. What is organizational burnout?
2. Screening for burnout?
3. Personal and Organizational Consequences of Burnout
4. JD-R Model
5. SDT and Basic Needs Theory
6. What organizations are currently doing?
7. Opportunities for improvement
8. What's next?

Jesse Gavin serves as the Wellness Director for Baylor College of Medicine (BCM) in Houston, TX. Since implementing the program in 2014, BCM has won numerous awards, including being named the nation’s 3rd Healthiest Employer by Healthiest Employers LLC in 2021, 2018 WELCOA Well Workplace - Silver award winner and 2019 KOOP National Health Award winner. Jesse received a Bachelor’s and Master’s Degree in Fitness and Human Performance. He is also currently pursuing a DrPH (Doctor of Public Health) degree from UTHealth School of Public Health.

Click Here to Purchase CEU's

 

 

August 10, 10:00am to 11:00am 2022  CT

Topic: Tricky Neuro Genes: An Overview and Update

Presented By: Neuro SIG 

Description: This webinar will touch on four genes in the neuro space, some of which have been an established part of a genetic counseling training program curriculum, and others more recently discovered. Testing for these genes is not straight-forward, and we will highlight their significance and aspects to consider when ordering testing for them.

Learning Objectives 

•Indicate the primary disease mechanism for RFC1-related CANVAS/Spectrum disorder and how genetic testing is performed

•Evaluate the utility of optical mapping in the context of genetic testing for FSHD.

•Summarize the nuances of GBA gene testing as it relates to Parkinson’s disease

•List the key features of SORD-neuropathy

 

Speaker: Soma Das

Soma Das, PhD, FACMG, is a director of the Genetic Services Laboratory at the University of Chicago where she has been the director since 1996.  She is one of the pioneers of the molecular diagnostics of rare orphan genetic conditions. A particular interest of hers is in the diagnostics of neurological conditions.

Speaker: Rojan Kavosh

Rojan Kavosh, MS, CGC, is a licensed certified genetic counselor and a Genomic Testing Consultant at PerkinElmer Genomics. Prior to joining PerkinElmer Genomics, she worked as a perinatal genetic counselor in the Fetal Center at Stanford Children’s Hospital. Rojan graduated from UCLA with a degree in Molecular, Cell and Developmental Biology, and earned her Master’s in Genetic Counseling from UC Irvine.

Speaker: Michelle Rochman

Michelle Rochman, MS, CGC, graduated from Thomas Jefferson University's Human Genetics and Genetic counseling master's program in 2021. She currently works at Jefferson in an adult neurology clinical practice where she counsels patients with various movement disorders. 

Speaker: Tara Jones

Tara Jones, MS, CGC, (she/her) is a genetic counselor in adult neurology at Cedars-Sinai in Los Angeles, specializing in neuromuscular and dementia indications. Tara currently serves as co-chair for the NeuroSIG Grant and Webinar Subcommittees. Her research interests include data-driven service delivery models to improve patient and provider outcomes regarding pre-symptomatic genetic testing. 

Click Here to Purchase CEU's 

 

 

August 10, 2022  12:00pm to 1:00pm CT

Topic: Utility of Genetics in Pediatric Solid Organ Transplant Evaluation 

Presented By: Inpatient SIG 

Description: 30-45 minutes to discuss current transplant policies, review of the literature, and discussion of ethical considerations with 15-20 minutes to allow for questions

Learning Objective #1

Review the current use of genetics within transplant programs

Learning Objective #2

Discuss the utility of genomics and WGS in the transplant evaluation process

 

Speaker: Nicole Choy MS, LCGC, nicole.x.choy@kp.org, Kaiser Permanente

Speaker: Amber Hildreth DO, AHildreth1@rchsd.org, Rady Children's Hospital

 

Click Here to Purchase CEU's 

 

September 7, 2022 12:00pm-1:00pm CT

Topic: Non-positional Leadership: How to grow your leadership skills without a leadership title

*All attendees that attend live will be eligible for our raffle to win one of 10 surprise items! Hope to see you there!*

Presented By: Leadership & Management SIG 

Learning Objective #1
Summarize the definition of non-positional leadership and different leadership styles.

Learning Objective #2
Distinguish between multiple assessments for determining your strengths/communication style.

Learning Objective #3
Highlight a pilot GC experience of integrating peer-to-peer mentorship into professional development.

Learning Objective #4
Identify several resources and tips for growing leadership ability.

Please share a brief outline of how you will utilize the hour webinar time.
We will have three unique topics, each taking 15-20 minutes each. All questions will be addressed at the end of the webinar.

Speaker #1 
Julie Hufham, jhufham@oncocyte.com , Oncocyte

Speaker #2 
Anna Essendrup, Essendrup.Anna@mayo.edu, Mayo Clinic Laboratories

Speaker #3 
Carrie Lahner, Lahner.Carrie@mayo.edu, Mayo Clinic Laboratories

Speaker #4 
Sara Mokhtary, sara.nasrine@gmail.com, Texas Oncology

Please describe how this session will address Justice, Equity, Diversity, and Inclusion issues relative to the speakers, audience, patient population, and/or other relevant components and content of the session proposal.

While none of these topics are specific to JEDI issues, we believe that leadership skills and mentorship can be used to improve inclusion, equity and diversity in the field of genetic counseling and the career development of all genetic counselors.

Click Here to Purchase CEU's

 

September 21, 2022 12:00pm-1:00pm CT

Topic: Any GC can be an international GC: Advancing and supporting global genetic counseling from the US  

Presented By: International SIG 

Learning Objective #1

Summarize the process of forming a genetic counselling professional society outside the United States

Learning Objective #2

Apply transferable genetic counselling skills to train allied healthcare professionals globally

Learning Objective #3

Identify strategies to create and support genetic counselling training programs outside the United States

 

Please share a brief outline of how you will utilize the hour webinar time.

Intro- 5 min - Grace

Daniela Diaz Caro - 15 min

Speaker will describe the field of genetics and genetic counseling in Latin America and her role in developing SPLAGen. She will describe the need, background, goals, process, and any outcomes associated with the SPLAGen.

Michelle Jacobs - 15 min

Speaker will describe the field of genetics and genetic counseling in Ethiopia, her efforts in educating nurses to conduct genetic counseling, and outcomes from this initiative.

Aisha Furqan - 15 min

Speaker will describe the field of genetics and genetic counseling in Pakistan and her role in developing a GC training program (in process). She will describe the need, background, goals, process, and outcomes associated with raising awareness through webinars and remote clinical collaborations.

Speaker #1 

Daniela Diaz Caro, danieladiazcaro@outlook.com, Columbia University

Speaker #2 

Michelle Jacobs, mfjac@med.umich.edu, University of Michigan

Speaker #3 

Aisha Furqan, aishafurqan@gmail.com, Natera

Please describe how this session will address Justice, Equity, Diversity, and Inclusion issues relative to the speakers, audience, patient population, and/or other relevant components and content of the session proposal.

This webinar describes how genetic counselors are using their diverse skillset to impact access to genetic counseling education and care on a global scale. It also highlights current efforts in countries that have been underrepresented in existing genetic counseling literature and discussions.

Click Here to Purchase CEU's 

 

 

October 19, 2022, 12:00pm-1:00pm CT

Presented By: Neurogenetics SIG 

Genetic Testing for the Epilepsies: A New Practice Guideline

Description: 

Learning Objective #1
Review the GRADE process for developing evidence-based guidelines

Learning Objective #2
Explore the key findings from the systematic evidence review and meta analysis.

Learning Objective #3
Discuss genetic testing strategies in the epilepsy patient population

Speaker: Beth Rosen Sheidley

Beth Rosen Sheidley, MS, CGC, is a licensed genetic counselor with over 25 years of experience in clinical genetic counseling, research and teaching. Her career has focused on the genetic basis of common neurodevelopmental and/or psychiatric illness, including autism, epilepsy and bipolar disorder. For the last decade, Beth has served as Co-Director of the Epilepsy Genetics Program at Boston Children’s Hospital and the Senior Genetic Counseling Program Manager for Neurology, overseeing a team of genetic counselors who provide services to pediatric patients with neurodevelopmental phenotypes and conduct clinical research. Beth is one of the founding members and Co-Chair of EpiGC, an international network of genetic counselors who specialize in epilepsy genetics.  She is a PAB member for the Epilepsy Foundation and the Co-Editor of Genetics for the Epilepsy Foundation website.  Beth served as the lead author of a systematic review of the epilepsy genetics literature for the NSGC, which was then utilized for the creation of the NSGC’s professional practice guideline.

Speaker: Lacey Smith
Lacey Smith, MS, CGC, is a clinical and academic genetic counselor within the Epilepsy Genetics Program at Boston Children’s Hospital, where she serves as the Genetic Counseling Program Manager for Epilepsy Genomics. Her research interests aim to better understand the genetic contributions to the epilepsies, particularly through ES/GS studies and collaborative gene discovery efforts. She is a coordinator of the ClinGen Epilepsy Sodium Channel Variant Curation Expert Panel, incorporating both gene- and disease-specific expertise into modifying variant classification rules. She is a member of the professional advisory board of the Epilepsy Foundation of New England and was co-lead author of the NSGC Practice Guideline for Genetic Testing and Counseling for the Epilepsies.

Speaker: Natalie Lippa

Natalie Lippa, MS, CGC, is an Assistant Professor of Genetic Counseling at Columbia University Irving Medical Center (CUIMC) and is the Co-Director of Genetic Counseling at the Institute for Genomic Medicine (IGM) . Since joining the CUIMC, she has focused on the genetics of neurological disease with a particular interest in epilepsy. In this research role, she consents patients, curates variants and assesses genotype-phenotype correlations with the goal of communicating diagnostic results back to families.  She is currently working as NSGCs lead author on an Evidence Based Practice Guideline for Genetic Testing in the Epilepsies.

Click Here to Purchase CEU's 

 

 

October 20, 2022 12:00pm-1:00pm CT

Presented By: Lab & Industry SIG

Current applications and future innovations for somatic testing in oncology care

Description

Learning Objective #1
Examine features and access of ctDNA/somatic testing in oncology care

Learning Objective #2
Define the relationship between somatic and germline testing

Learning Objective #3
Illustrate new applications using ctDNA across the continuum of cancer care

Learning Objective #4
Summarize how genetic counselors can adapt skillsets as the somatic testing space as it evolves

The Webinar will provide a brief overview of somatic testing background and applications in oncology care, while highlighting the differences and complements to germline testing GCs are familiar with. We will then highlight future applications of somatic testing across the cancer continuum and highlight how GCs can adapt their skills to work in such evolving settings.

Speaker #1
Leslie Bucheit, lesliebucheit@gmail.com, Guardant Health

Speaker #2 
Kali Chatham Dougherty, kalindougherty@gmail.com, Foundation Medicine

We will address how access issues to somatic testing are exacerbated in the oncology treatment setting.

Click Here to Purchase CEU's

 

 

October 26th, 2022 10:00am-11:00am CT

Topic: One Concrete Step towards Culturally Engaged Supervision

Learning Objective #1
Define culturally engaged supervision and its importance in the supervision process

Learning Objective #2
Examine communication as a fundamental strategy to facilitate culturally engaged supervision

Learning Objective #3
Reflect on personal communication style and the impact on the supervision process

Please share a brief outline of how you will utilize the hour webinar time.

1) Present current literature on cultural engagement in supervision and definitions and supervision competencies that support its' importance. Didactic via powerpoint. 2) Discuss communication and the opportunities and challenges it presents in facilitating cultural engaged supervision. Didactic via powerpoint. 3) Introduce a communication style assessment for participants to take individually and then facilitation of a large group discussion about how this impact the supervision process.

Speaker #1 
Krista Redlinger-Grosse, redli009@umn.edu, University of Minnesota

Speaker #2 
Ian MacFarlane, macf0010@umn.edu, University of Minnesota

Click Here to Purchase CEU's 

 

 

November 2, 2022, 12:00pm-1:00pm CT

Topic: Congenital Heart Disease: Considerations for Fetal and Maternal Management

Presented By: Prenatal SIG 

Learning Objective #1
Review the etiology of congenital heart disease and genetic testing approaches

Learning Objective #2
Demonstrate genetic counselors’ role and approach to counseling on fetal CHD

Learning Objective #3
Understand MFM management for maternal congenital heart disease and importance of a multidisciplinary team

Learning Objective #4
Describe the role of the genetic counselor in the multidisciplinary team approach to maternal CHDs

Please share a brief outline of how you will utilize the hour webinar time.
1. Brief overview of genetics of CHD (15 min) 2. Approach to fetal CHD (15 min) 3. Maternal management of CHD (15 min) 3. GC role in maternal CHD (5 min) 4. Questions (5-10 min)

Speaker #1
Benjamin Helm, bmhelm@iu.edu, Indiana University School of Medicine

Speaker #2
Allison Schartman, aschartman@iuhealth.org, Indiana University Health

Speaker #3
Caroline Rouse, MD, cerouse@iu.edu, Indiana University Health

Speaker #4
Kristyne Stone, kstone6@iuhealth.org, Indiana University Health

Click Here to Purchase CEU's 

 

November 10, 2022, 12:00pm-1:00pm CT

Presented By: NSGC Webinar Subcommittee

Genetic Counselor Awareness Day Webinar - Broadening Genetic Counselors’ Career Paths: The Roads Less Traveled. Genetic Counseling isn't a job, it's a skillset!

Learning Objectives:
-Describe how genetic counselors have leveraged the GC skill set to expand the boundaries of their career paths.
-Explore the benefits and challenges of maintaining connections to the GC community while taking a diverging career path.
-Identify resources for developing or reframing your skill sets to seek out new opportunities.

Click Here to Purchase CEU's 

 

 

November 30, 2022, 12:00pm-1:00pm CT

Topic: Evaluating genetic diseases in nephrology, in kidney transplant candidates and in living kidney donors

Presented By: Renal SIG 

Learning Objective #1

• Recognize the importance of making a genetic diagnosis in nephrology

Learning Objective #2

• Understand that testing living kidney donors for genetic disease, if done responsibly, can inform risk of future ESRD and improve decision making

Learning Objective #3

• Review case examples to illustrate the role and impact of genetic testing

Please share a brief outline of how you will utilize the hour webinar time.

A brief introduction will give a perspective of genetic testing compared to other techniques to advance diagnosis in kidney diseases.  This will be followed by an overview of the benefits of testing on diagnosis, prognosis and management including post-transplant management.  I will then cover the diagnosis rate of genetic testing for polycystic kidney disease and diagnosis rate in all comers with chronic kidney disease.  Following this, I will discuss a testing algorithm for healthy asymptomatic people, biologically related to patients with possibly monogenic chronic kidney disease, who wish to be living kidney donors.  Finally, I will use case examples to illustrate how genetic testing can and should be used in nephrology, kidney transplantation and living kidney donation.

Speaker #1

Christie P Thomas MD

Professor and Vice-Chair, Faculty Advancement, Department of Internal Medicine

Director, Renal Genetics Clinic

University of Iowa Carver College of Medicine

Iowa City, IA

Christie-thomas@uiowa.edu

Please describe how this session will address Justice, Equity, Diversity, and Inclusion issues relative to the speakers, audience, patient population, and/or other relevant components and content of the session proposal.

This session is focused on genetic testing in nephrology and transplantation and applies to diverse populations, although every community does not have equal access to genetic testing in the healthcare setting.  As a result of this webinar, I hope that genetic counselors will have a better understanding of the role of genetic testing in nephrology and be able to apply it to people regardless  of their socioeconomic status, background or ancestry.

Click Here to Purchase CEU's 

 

 

December 7, 2022, 12:00pm-1:00pm CT

Topic: Emerging Technologies in Rare Disease Research: Experiences from the Undiagnosed Diseases Network

Presented by: Genomic Technology SIG 

Learning Objective #1

Review the application of emerging genomic technologies in a rare disease population

Learning Objective #2

Review the benefits and limitations of emerging genomic technologies

 

Please share a brief outline of how you will utilize the hour webinar time.

10 minutes for introduction of the UDN, 40 minutes for discussion of specific cases from the UDN and background on technology used, 10 minutes for Q&A

 

Speaker #1 

Rachel Mahoney, rachel_mahoney@hms.harvard.edu, Harvard Medical School

Speaker #2 

Devon Bonner, devonbonner@stanfordhealthcare.org, Stanford University

Click Here to Purchase CEU's 

 

December 14, 2022, 1:00pm-2:00pm CT

Topic: Still Shooting for the Moon: Updates on the Cancer Moonshot Initiative

Learning Objective #1

Define the currently funded inherited cancer moonshot projects

Learning Objective #2

Outline the President’s Cancer Panel Report: Closing Gaps in Cancer Screening for All Americans

Speaker #1 

Heather Hampel

Speaker #2 

Alanna Rahm

Click here to Purchase CEU's 

 

 

 

2021 Webinar Series

2021 Webinar Series Recordings

The NSGC Member Webinar Series Recordings are now available for up to 5.0 Contact Hours. These webinars are on timely year-round education on issues impacting our profession. From strategies to increase gender inclusion to developing career ladders, these webinars keep you apprised of best practices and the latest professional issues and career development support.

Pricing: $100/members; $130 non-members (20% discount offered for members through 12/31/2021; discounted price: $80)

Purchase the 2021 Member Webinar Series Recordings

2021 Past Webinars

Genetic Counselor Awareness Day Webinar

Genetic Counselors in the Community: You Get So Much When You Give

November 4, 2021, 1:00 pm ET/12:00 pm CT/11:00 am MT/10:00 am PT

Learning Objectives:

• Identify ways that genetic counselors have served as advocates for patients within their communities.
• Describe genetic counseling skills that may translate to community outreach and advocacy work.
• Review the personal and professional benefits that may result from advocacy and community outreach work.
• Describe key takeaways from community outreach work and how these takeaways have contributed to enhancing genetic counseling skills.

Speakers:

• Pilar Magoulas, MS, CGC
• Kira Dineen, MS, LCGC, CG(ASCP)CM
• Susan Walther, MS, CGC
• Rachel Donnell, MMSc, CGC

View Recording

The Only Constant is Change: An Overview of the Evolution of Genetic Counseling Training in North America

Live webinar date: October 13, 2021, 1:00 pm ET/12:00 pm CT/11:00 am MT/10:00 am PT

Learning Objectives:

• Describe the landscape of genetic counseling graduate education in North America.
• Explain the basics of the Genetic Counseling Admissions Match.
• Identify three ways in which the Standards of Accreditation for Graduate Programs in Genetic Counseling have evolved in the last decade.
• Discuss one region’s adaptations to genetic counseling training in response to the covid-19 pandemic.

Speakers: Dawn Allain, Amanda Bergner

View Recording

Follow-up Q&A

Beyond the Binary: Gender Diversity in Genetic Counseling 

View Recording

Live Webinar Date: Tuesday, June 22, 1:00 pm EDT/12:00 pm CDT/11:00 am MDT/10:00 am PDT

Presented by: 

• Kim Zayhowski (she/her), MS, CGC, Boston Medical Center and Boston University’s Genetic Counseling Program
• Tala Berro (she/they), MS, CGC, Brigham and Women’s Hospital 

Learning Objectives: 

• Explain terminology related to sex and gender. 
• Provide strategies to increase gender inclusion in genetic counseling sessions. 
• Highlight the need for gender inclusion within and beyond the genetic counseling field.
   

Climbing Ladders and Swinging Branches: Establishing Roots to Support Genetic Counselor Professional Advancement 

View Recording

 

Presented by: 

• Kathleen Gewandter, MGC, CGC, Moffitt Cancer Center 
• Dawn Laney, MS, CGC, CCRC, Emory Department of Human Genetics 
• Kiley Johnson, MS, LCGC, GeneMatters 
• Yiru C Zhao, PhD, MS, CGC, Genescreen 

Learning Objectives: 

• Contrast innovative new approaches to career ladder development and adjustments amongst various settings, including academic, industry and clinical. 
• Demonstrate what goes into the development of a career ladder. 
• Discuss how to leverage the career ladder for your own professional benefit. 
• Apply data compiled across multiple career paths to better understand the experiences of genetic counselors related to career progression.
   

Antiracism in Action: Genetic Counseling Trainee Platform for Racial Justice

View Recording

 

Presented by:

• Gianna Petrelli
• Rushna Raza
• Smriti Singh
• Sofia Horan
• Melissa Gandhi

Learning Objectives:

• Define the history, mission and organizational structure of Genetic Counseling Trainee Platform for Racial Justice (GCRJ)
• Discuss challenges, insights and successes in a community centered grassroots organization.
• Explore how genetic counselors can incorporate anti-racism into their work and considerations for teaching and supervision. 

NSGC Member Webinar Series Archives

To view the library of past NSGC Member Webinar Series recordings, please click here.

 

NSGC Sponsored Webinar Series

May 25, 2022: Polygenic Risk Scores for All: Strategies for Applying PRS in Diverse Ancestries for the Prevention of Common Disease

 

Are you interested in learning more about how to report on polygenic risk score (PRS) analysis for common diseases for patients of diverse ancestries?

Join us for an informational webinar on the latest clinical applications of PRS & the role of ancestry on Wednesday, May 25th at 12PM Eastern.

Dr. George Busby, and Emma Perez will cover the crucial role of PRS in precision risk assessment and how to best report on PRS for diverse individuals. Their presentation will be followed by a live Q&A.

During this webinar, you will learn about:

• The latest clinical applications for PRS analysis and reporting in multiple ancestries
• Approaches for ancestry-informed PRS analysis
• Ongoing research efforts to increase diversity in genomics research

For more information, contact info@allelica.com

 

Have an Idea for a Webinar Topic?

Do you have an idea for a webinar, online course, or other education for genetic counselors? Share your ideas with the NSGC Education Committee by submitting your idea here. The NSGC Education Committee reviews submissions on a monthly basis and follows up with submitters shortly thereafter. You will be contacted by an NSGC volunteer to follow up on your submission.